Digital Alongside diagnosis: AI’s role in shaping health transformat... Humans are about to go hybrid – in fact, our race is undergoing its own digital transformation.
R&D Defining innovation: The battle for clarity, access, and sta... The pharmaceutical industry often claims its medicines as highly innovative and expects to be compensated accordingly.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.